The global breast biopsy devices market is growing at 8.5% CAGR owing to rising prevalence of breast cancer in female population globally is one of the key rivers for the growth of the global breast biopsy devices market. The increase in number of breast cancer screening programs due to initiatives by government and rising demand for minimally invasive and non-invasive procedures due to the benefits offered like speedy recovery and less pain will propel the growth of the breast biopsy devices market. Furthermore, the increasing awareness about early detection of breast cancer and favourable reimbursement scenario will fuel the growth in the breast biopsy devices market.

The growing population, increasing expenditure on healthcare and initiatives by public organizations regarding female health problems will accelerate the growth of the breast biopsy devices market. Nevertheless, the innovation of liquid biopsy and promising clinical trail will create promising opportunities for growth in the global breast biopsy devices market.

The COVID-19 pandemic has had a negative impact on breast biopsy devices market owing to limited access to clinics & hospitals, social distancing norms, and lockdown measures.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/breast-biopsy-devices-market/request-sample

Based on product, the biopsy needles contributes to the largest share in the breast biopsy devices market owing to the increased adoption of image guided procedures in developed and emerging economies, rising demand for minimally invasive procedures, and the introduction of technologically advanced and novel designs.

North America dominates the breast biopsy devices market owing to the rising cases of breast cancer, growing geriatric population, increased expenditure on healthcare, economic prosperity, and expansion of private healthcare sector.

Hologic has received the European CE mark for Breva Breast Biopsy System with CorLumina Imaging Technology. The system is designed to improve biopsy accuracy, improve patient satisfaction, and streamline the biopsy suite workflow through real-time imaging.

The prominent players in the breast biopsy devices industry include Becton, Dickinson and Company, Cook Medical Incorporated, Hologic Inc., Medtronic PLC., Sterylab S.R.L., Danaher Corporation, Siemens AG, Intact Medical Corporation, and Planmed Oy.

Source: VynZ Research